Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Charitable Contribution | $38,456 | 2 | 87.6% |
| Food and Beverage | $5,187 | 357 | 11.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $130.46 | 9 | 0.3% |
| Education | $107.89 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Cadwell Industries, INC | $38,456 | 2 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $527.87 | 32 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $470.04 | 33 | $0 (2019) |
| Supernus Pharmaceuticals, Inc. | $362.83 | 29 | $0 (2019) |
| ACADIA Pharmaceuticals Inc | $300.20 | 26 | $0 (2019) |
| ABBVIE INC. | $292.90 | 15 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $290.55 | 19 | $0 (2019) |
| UCB, Inc. | $264.00 | 18 | $0 (2019) |
| Genentech USA, Inc. | $254.14 | 19 | $0 (2019) |
| Amgen Inc. | $242.23 | 16 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17.24 | 1 | ABBVIE INC. ($17.24) |
| 2023 | $35.37 | 2 | ABBVIE INC. ($35.37) |
| 2022 | $72.73 | 1 | ABBVIE INC. ($72.73) |
| 2021 | $72.66 | 4 | AbbVie Inc. ($72.66) |
| 2020 | $24.08 | 2 | Allergan, Inc. ($15.19) |
| 2019 | $562.95 | 36 | Novartis Pharmaceuticals Corporation ($107.48) |
| 2018 | $24,180 | 176 | Cadwell Industries, INC ($21,708) |
| 2017 | $18,916 | 148 | Cadwell Industries, INC ($16,748) |
All Payment Transactions
370 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/21/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 02/07/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: NEUROSCIENCE | ||||||
| 05/17/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $72.73 | General |
| Category: NEUROSCIENCE | ||||||
| 09/21/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: NEUROSCIENCE | ||||||
| 09/21/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: NEUROSCIENCE | ||||||
| 08/26/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $25.77 | General |
| Category: NEUROSCIENCE | ||||||
| 08/03/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: NEUROSCIENCE | ||||||
| 09/23/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: NEUROSCIENCE | ||||||
| 06/08/2020 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Education | In-kind items and services | $8.89 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2019 | Novartis Pharmaceuticals Corporation | AIMOVIG (Biological) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: NEUROSCIENCE | ||||||
| 05/16/2019 | CSL Behring | Hizentra (Biological) | Food and Beverage | Cash or cash equivalent | $22.47 | General |
| Category: Immunology | ||||||
| 05/03/2019 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $14.27 | General |
| Category: PARKINSONS DISEASE | ||||||
| 04/30/2019 | GENZYME CORPORATION | AUBAGIO (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 03/27/2019 | CSL Behring | Hizentra (Biological) | Food and Beverage | Cash or cash equivalent | $11.50 | General |
| Category: Immunology | ||||||
| 03/25/2019 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $12.45 | General |
| Category: CNS | ||||||
| 03/18/2019 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: Central Nervous System | ||||||
| 03/13/2019 | Novartis Pharmaceuticals Corporation | AIMOVIG (Biological) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: NEUROSCIENCE | ||||||
| 03/11/2019 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $14.85 | General |
| 03/07/2019 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 03/05/2019 | Genentech USA, Inc. | OCREVUS (Biological) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Immunology | ||||||
| 03/04/2019 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $14.39 | General |
| Category: PARKINSONS DISEASE | ||||||
| 02/28/2019 | Mallinckrodt Enterprises LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 02/28/2019 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Neuroscience | ||||||
| 02/27/2019 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: pseudobulbar affect (PBA) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,060 | 1,362 | $378,863 | $154,352 |
| 2022 | 10 | 907 | 1,145 | $325,014 | $140,707 |
| 2021 | 9 | 953 | 1,230 | $348,582 | $153,578 |
| 2020 | 11 | 927 | 1,212 | $334,162 | $132,096 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 132 | 133 | $59,850 | $41,005 | 68.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 307 | 412 | $82,400 | $31,671 | 38.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 224 | 224 | $60,480 | $24,627 | 40.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 175 | 368 | $92,000 | $24,485 | 26.6% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 65 | 65 | $34,125 | $13,440 | 39.4% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 81 | 82 | $31,734 | $12,109 | 38.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 46 | 48 | $7,200 | $2,647 | 36.8% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 19 | 19 | $6,080 | $2,377 | 39.1% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 11 | 11 | $4,994 | $1,993 | 39.9% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2022 | 134 | 134 | $60,300 | $41,713 | 69.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 244 | 244 | $65,880 | $27,384 | 41.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 182 | 257 | $51,470 | $22,516 | 43.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 147 | 307 | $76,750 | $20,796 | 27.1% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2022 | 52 | 52 | $27,300 | $11,013 | 40.3% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 56 | 56 | $21,672 | $8,803 | 40.6% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 25 | 27 | $8,640 | $3,302 | 38.2% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 13 | 13 | $5,902 | $2,294 | 38.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 31 | 32 | $4,800 | $2,182 | 45.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 23 | 23 | $2,300 | $704.88 | 30.6% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Office | 2021 | 123 | 124 | $55,800 | $40,296 | 72.2% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 180 | 381 | $95,250 | $27,455 | 28.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 220 | 220 | $59,400 | $26,450 | 44.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 201 | 274 | $54,800 | $23,931 | 43.7% |
| 95913 | Nerve transmission studies, 13 or more studies | Office | 2021 | 79 | 79 | $41,475 | $17,814 | 43.0% |
| 95911 | Nerve transmission studies, 9-10 studies | Office | 2021 | 60 | 61 | $23,607 | $10,326 | 43.7% |
About Dr. Gregory Lipscomb, M.D
Dr. Gregory Lipscomb, M.D is a Neurology healthcare provider based in Montgomery, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2008. The National Provider Identifier (NPI) number assigned to this provider is 1427218114.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Lipscomb, M.D has received a total of $43,881 in payments from pharmaceutical and medical device companies, with $17.24 received in 2024. These payments were reported across 370 transactions from 36 companies. The most common payment nature is "Charitable Contribution" ($38,456).
As a Medicare-enrolled provider, Lipscomb has provided services to 3,847 Medicare beneficiaries, totaling 4,949 services with total Medicare billing of $580,733. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Montgomery, AL
- Active Since 06/16/2008
- Last Updated 07/25/2024
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1427218114
Products in Payments
- Arc Essentia EEG (Device) $21,708
- Cadwell Arc Essentia (Device) $16,748
- GILENYA (Drug) $362.42
- COPAXONE (Drug) $303.19
- NUPLAZID (Drug) $300.20
- APTIOM (Drug) $290.55
- TROKENDI XR (Drug) $286.66
- OCREVUS (Biological) $254.14
- Betaseron (Drug) $205.11
- Aimovig (Biological) $175.48
- Briviact (Drug) $173.22
- QUDEXY XR Topiramate Extended Release Capsules (Drug) $161.16
- UBRELVY (Drug) $160.58
- NUEDEXTA (Drug) $147.99
- ONFI (Drug) $147.01
- Fycompa (Drug) $146.81
- AIMOVIG (Biological) $124.32
- TECFIDERA (Drug) $118.13
- TYSABRI (Biological) $117.27
- ACTHAR (Biological) $106.54
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Montgomery
Dr. Larry Epperson, Md, MD
Neurology — Payments: $34,002
Hamp Greene, M.d, M.D
Neurology — Payments: $19,723
Dr. Vamshi Krishna Sai Balasetti, M.d, M.D
Neurology — Payments: $18,192
Dr. Paul Miller, Md, MD
Neurology — Payments: $11,973
Richard Chin, M.d, M.D
Neurology — Payments: $10,573
Sanath Kasi Reddy, Md, MD
Neurology — Payments: $4,274